Financière de Tubize SA (TUB.BR)
EUR 138.8
(-0.86%)
EUR 138.8
(-0.86%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.98 EUR | -49.36% |
| 2022 | 3.91 EUR | -54.22% |
| 2021 | 8.54 EUR | 45.98% |
| 2020 | 5.85 EUR | 150100.0% |
| 2019 | -0.00 EUR | -100.06% |
| 2018 | 6.41 EUR | -0.16% |
| 2017 | 6.42 EUR | 57.74% |
| 2016 | 4.07 EUR | -14.68% |
| 2015 | 4.77 EUR | 250.74% |
| 2014 | 1.36 EUR | -1.45% |
| 2013 | 1.38 EUR | -20.69% |
| 2012 | 1.74 EUR | 20.0% |
| 2011 | 1.45 EUR | 208.51% |
| 2010 | 0.47 EUR | -87.16% |
| 2009 | 3.66 EUR | 18129.56% |
| 2008 | -0.02 EUR | -102.28% |
| 2007 | 0.89 EUR | -91.68% |
| 2006 | 10.70 EUR | 62.37% |
| 2005 | 6.59 EUR | 142.28% |
| 2004 | 2.72 EUR | -26.29% |
| 2003 | 3.69 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 2.09 EUR | 0.0% |
| 2023 Q4 | -0.07 EUR | 0.0% |
| 2023 Q2 | 2.05 EUR | 0.0% |
| 2023 FY | - EUR | -49.36% |
| 2022 FY | - EUR | -54.22% |
| 2022 Q2 | 3.25 EUR | 0.0% |
| 2022 Q4 | -1.33 EUR | 0.0% |
| 2021 Q2 | 4.60 EUR | 0.0% |
| 2021 FY | - EUR | 45.98% |
| 2021 Q4 | 3.94 EUR | 0.0% |
| 2020 Q4 | 2.94 EUR | 0.0% |
| 2020 FY | - EUR | 150100.0% |
| 2020 Q2 | 2.91 EUR | 0.0% |
| 2019 FY | - EUR | -100.06% |
| 2019 Q2 | 3.31 EUR | 0.0% |
| 2019 Q4 | 1.00 EUR | 0.0% |
| 2018 FY | - EUR | -0.16% |
| 2018 Q1 | 3.22 EUR | 8.78% |
| 2018 Q4 | 1.97 EUR | 0.0% |
| 2018 Q2 | 4.43 EUR | 37.58% |
| 2017 Q2 | 3.46 EUR | 116.25% |
| 2017 FY | - EUR | 57.74% |
| 2017 Q4 | 2.96 EUR | 0.0% |
| 2017 Q1 | 1.60 EUR | -4.76% |
| 2016 FY | - EUR | -14.68% |
| 2016 Q4 | 1.68 EUR | 0.0% |
| 2016 Q2 | 2.39 EUR | 134.31% |
| 2016 Q1 | 1.02 EUR | -63.04% |
| 2015 FY | - EUR | 250.74% |
| 2015 Q3 | 1.19 EUR | -40.8% |
| 2015 Q4 | 2.76 EUR | 131.93% |
| 2015 Q2 | 2.01 EUR | 68.91% |
| 2015 Q1 | 1.19 EUR | 176.74% |
| 2014 Q4 | 0.43 EUR | 26.47% |
| 2014 FY | - EUR | -1.45% |
| 2014 Q3 | 0.34 EUR | -63.44% |
| 2014 Q1 | 0.34 EUR | -48.48% |
| 2014 Q2 | 0.93 EUR | 173.53% |
| 2013 Q2 | 0.33 EUR | -5.71% |
| 2013 Q1 | 0.35 EUR | 0.0% |
| 2013 Q4 | 0.66 EUR | 88.57% |
| 2013 Q3 | 0.35 EUR | 6.06% |
| 2013 FY | - EUR | -20.69% |
| 2012 Q1 | 0.44 EUR | 0.0% |
| 2012 FY | - EUR | 20.0% |
| 2012 Q3 | 0.44 EUR | 0.0% |
| 2012 Q4 | 0.35 EUR | -20.45% |
| 2012 Q2 | 0.44 EUR | 0.0% |
| 2011 Q3 | 0.36 EUR | 0.0% |
| 2011 FY | - EUR | 208.51% |
| 2011 Q4 | 0.44 EUR | 22.22% |
| 2011 Q2 | 0.36 EUR | 0.0% |
| 2011 Q1 | 0.36 EUR | 0.0% |
| 2010 Q4 | 0.36 EUR | 200.0% |
| 2010 Q1 | 0.12 EUR | 0.0% |
| 2010 FY | - EUR | -87.16% |
| 2010 Q3 | 0.12 EUR | 0.0% |
| 2010 Q2 | 0.12 EUR | 0.0% |
| 2009 Q4 | 0.12 EUR | -86.96% |
| 2009 Q1 | 0.92 EUR | 0.0% |
| 2009 Q2 | 0.92 EUR | 0.0% |
| 2009 FY | - EUR | 18129.56% |
| 2009 Q3 | 0.92 EUR | 0.0% |
| 2008 Q1 | -0.01 EUR | 0.0% |
| 2008 Q3 | -0.01 EUR | 0.0% |
| 2008 Q2 | -0.01 EUR | 0.0% |
| 2008 Q4 | 0.92 EUR | 18139.22% |
| 2008 FY | - EUR | -102.28% |
| 2007 Q2 | 0.22 EUR | 0.0% |
| 2007 Q4 | -0.01 EUR | -102.32% |
| 2007 Q1 | 0.22 EUR | 0.0% |
| 2007 Q3 | 0.22 EUR | 0.0% |
| 2007 FY | - EUR | -91.68% |
| 2006 Q1 | 2.67 EUR | 0.0% |
| 2006 Q2 | 2.67 EUR | 0.0% |
| 2006 Q3 | 2.67 EUR | 0.0% |
| 2006 Q4 | 0.22 EUR | -91.76% |
| 2006 FY | - EUR | 62.37% |
| 2005 FY | - EUR | 142.28% |
| 2005 Q4 | 2.67 EUR | 61.82% |
| 2005 Q3 | 1.65 EUR | 0.0% |
| 2005 Q2 | 1.65 EUR | 0.0% |
| 2005 Q1 | 1.65 EUR | 0.0% |
| 2004 Q4 | 1.65 EUR | 142.65% |
| 2004 Q2 | 0.68 EUR | 0.0% |
| 2004 Q3 | 0.68 EUR | 0.0% |
| 2004 Q1 | 0.68 EUR | 0.0% |
| 2004 FY | - EUR | -26.29% |
| 2003 Q3 | 0.92 EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2003 Q2 | 0.92 EUR | 0.0% |
| 2003 Q1 | 0.92 EUR | 0.0% |
| 2003 Q4 | 0.68 EUR | -26.09% |
| 2002 Q4 | 0.92 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | 1750.0% |
| ABIVAX Société Anonyme | -3.43 EUR | 157.726% |
| Adocia SA | -1.91 EUR | 203.665% |
| Aelis Farma SA | -0.39 EUR | 607.692% |
| Biophytis S.A. | -12.55 EUR | 115.777% |
| Advicenne S.A. | -0.67 EUR | 395.522% |
| genOway Société anonyme | 0.17 EUR | -1064.706% |
| IntegraGen SA | -0.03 EUR | 7744.788% |
| Medesis Pharma S.A. | -0.80 EUR | 347.5% |
| Neovacs S.A. | -0.00 EUR | 79300.0% |
| NFL Biosciences SA | -0.46 EUR | 530.435% |
| Plant Advanced Technologies SA | 0.07 EUR | -2728.571% |
| Quantum Genomics Société Anonyme | -0.09 EUR | 2275.824% |
| Sensorion SA | -0.17 EUR | 1264.706% |
| Theranexus Société Anonyme | -0.88 EUR | 325.0% |
| TME Pharma N.V. | -1.34 EUR | 247.761% |
| Valbiotis SA | -0.59 EUR | 435.593% |
| TheraVet SA | -0.49 EUR | 504.082% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | 1420.0% |
| argenx SE | -4.67 EUR | 142.398% |
| BioSenic S.A. | -0.21 EUR | 1042.857% |
| Celyad Oncology SA | -0.33 EUR | 700.0% |
| DBV Technologies S.A. | -0.71 EUR | 378.873% |
| Galapagos NV | 3.21 EUR | 38.318% |
| Genfit S.A. | -0.58 EUR | 441.379% |
| GeNeuro SA | -0.59 EUR | 435.593% |
| Hyloris Pharmaceuticals SA | -0.55 EUR | 460.0% |
| Innate Pharma S.A. | -0.09 EUR | 2204.145% |
| Inventiva S.A. | -2.43 EUR | 181.481% |
| MaaT Pharma SA | -1.73 EUR | 214.451% |
| MedinCell S.A. | -0.88 EUR | 325.0% |
| Nanobiotix S.A. | -1.08 EUR | 283.333% |
| Onward Medical N.V. | -1.20 EUR | 265.0% |
| Oryzon Genomics S.A. | -0.06 EUR | 3693.466% |
| OSE Immunotherapeutics SA | -1.18 EUR | 267.797% |
| Oxurion NV | -0.01 EUR | 17317.391% |
| Pharming Group N.V. | -0.01 EUR | 13755.172% |
| Poxel S.A. | -0.91 EUR | 317.582% |
| GenSight Biologics S.A. | -0.54 EUR | 466.667% |
| Transgene SA | -0.22 EUR | 1000.0% |
| UCB SA | 1.81 EUR | -9.392% |
| Valneva SE | -0.73 EUR | 371.233% |
| Vivoryon Therapeutics N.V. | -1.12 EUR | 276.786% |